PROS1 and COVID-19: Both in vitro and in vivo studies strongly suggest that the S protein, and even its S1 subunit, can contribute to the inflammatory process and the pathophysiology of long COVID syndrome (LC) or post-acute sequelae of COVID-19 (PASC) [9,10,11].